ISO Recertification Success
CIS Oncology are pleased to announce that once again we have passed our re-certification audit for ISO 13485:2016 Medical Devices-…
Read More...
2024 ChemoCare User Groups *Registration now Open*
Registration is now open for our 2024 Adult and Paediatric ChemoCare User Groups. You can register by going to the…
Read More...
SME Climate Commitment 2024
Climate action grows more important by the day. Small businesses – making up 90% of businesses worldwide – have a…
Read More...
ChemoCare goes live at Imperial College Healthcare NHS Trust
Many congratulations to Imperial College Healthcare NHS Trust (ICHT) on their recent Go Live with ChemoCare® for electronic chemotherapy prescribing…
Read More...
ISO Re-Certification Success
CIS Oncology are pleased to announce that we have passed our re-certification audit for ISO 9001 – Quality Management System…
Read More...
Leeds Go Live with Paediatric ChemoCare v6.07
CIS Oncology is pleased to announce that Leeds Teaching Hospitals (Paediatrics) is the latest CIS customer to go live with…
Read More...
CIS Oncology Support Service Team continues to provide customer satisfaction throughout 2023
Following a recent survey, all CIS Oncology’s Support Desk customers say they are “very satisfied” or “completely satisfied” with the…
Read More...
Cyber Essentials Plus Success
CIS Oncology Ltd is pleased to announce the successful renewal of their Cyber Essentials Plus certificate, issued by The IASME…
Read More...
ChemoCare – ChemoConsent
The CIS Oncology strategy underpins our commitment to make the treatment of cancer patients as smooth as possible. We aim…
Read More...
2023 BOPA Symposium – Thank You (Diolch)
Many thanks to all who visited our stand at #BOPA2023. Good to meet some of our current users and potential new…
Read More...